Xenon Pharmaceuticals Inc. · NASDAQ:XENE
Cannon Gillian sold 1,190 Xenon Pharmaceuticals Inc. shares (Form 4)
Traded Jun 5, 2026 · Filed Jun 8, 2026
On Jun 5, 2026, Cannon Gillian (Director) sold 1,190 Xenon Pharmaceuticals Inc. shares at US$53.14 for US$63,237 under a trading plan, leaving 1,455 shares. Filed Jun 8, 2026 (Form 4).
- Sold
- 1,190 shares
- Price
- US$53.14
- Value
- US$63,237
- Holding after
- 1,455 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Shares | Sale | 1,190 | US$53.14 | 1,455 | Direct |
Source
Related
- Xenon Pharmaceuticals Inc.
- Cannon Gillian
- Xenon Pharmaceuticals Inc. shareholders
- Form 4 · Cannon Gillian · Jun 3, 2026
- Form 4 · Kelly Thomas Patrick · Oct 16, 2026
- Form 4 · Kelly Thomas Patrick · Oct 1, 2026
- Form 4 · Mortimer Ian · Oct 1, 2026
- Form 4 · Svoronos Dawn · Sep 3, 2026
- Form 4 · Kenney Christopher John · Aug 31, 2026